Downregulation of FHL1 expression is significantly associated with poorer overall survival (OS) in various cancer types, including gastric cancer, head-and-neck squamous cell carcinoma66, and esophageal squamous cell carcinoma. Here, FHL1 is linked to esophageal squamous cell carcinoma.